Tomlinson (pictured) served as an executive director at GlaxoSmithKline Pharmaceuticals, where he led a variety of research and analysis teams over the last five years. Before joining GSK, Tomlinson was a manager at ZS Associates.

In his new role he will be responsible for KJT’s custom research teams, as well as the professional development of the firm’s research staff.

KJT Group president Kenneth Tomaszewski said: “Jeff brings a new level of insight to our existing and potential clients, having extensive and successful experience on their side of the equation. I can’t imagine a better fit for our company at this stage of our development. We are extremely fortunate to have someone with his background and character working with our teams.”